C. Robinson

714 total citations
12 papers, 534 citations indexed

About

C. Robinson is a scholar working on Physiology, Epidemiology and Rheumatology. According to data from OpenAlex, C. Robinson has authored 12 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 4 papers in Epidemiology and 4 papers in Rheumatology. Recurrent topics in C. Robinson's work include Lysosomal Storage Disorders Research (7 papers), Glycogen Storage Diseases and Myoclonus (4 papers) and Mycobacterium research and diagnosis (3 papers). C. Robinson is often cited by papers focused on Lysosomal Storage Disorders Research (7 papers), Glycogen Storage Diseases and Myoclonus (4 papers) and Mycobacterium research and diagnosis (3 papers). C. Robinson collaborates with scholars based in United States, Canada and Germany. C. Robinson's co-authors include Markus Ries, Raphael Schiffmann, Roscoe O. Brady, Margaret Timmons, Roscoe O. Brady, David F. Moore, William Benko, Hassan Askari, Scott C. Garman and James M. Dambrosia and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PEDIATRICS and Journal of the American Society of Nephrology.

In The Last Decade

C. Robinson

11 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Robinson United States 8 454 208 170 139 123 12 534
I. Willers Germany 8 366 0.8× 197 0.9× 146 0.9× 90 0.6× 106 0.9× 25 497
Laila Arash Germany 7 565 1.2× 284 1.4× 174 1.0× 93 0.7× 59 0.5× 8 629
M. Smith United Kingdom 4 387 0.9× 165 0.8× 166 1.0× 55 0.4× 26 0.2× 5 454
W.P. de Groot Netherlands 15 217 0.5× 63 0.3× 84 0.5× 34 0.2× 143 1.2× 25 494
Shelley Collins United States 9 246 0.5× 84 0.4× 103 0.6× 48 0.3× 22 0.2× 13 453
Andrew Lischuk United States 10 191 0.4× 61 0.3× 8 0.0× 52 0.4× 90 0.7× 14 395
Naresh Kumar Meena United States 8 112 0.2× 85 0.4× 53 0.3× 19 0.1× 39 0.3× 13 290
M Chaâbouni Tunisia 12 97 0.2× 89 0.4× 33 0.2× 39 0.3× 21 0.2× 43 369
Lorenzo Pavone Italy 8 55 0.1× 16 0.1× 78 0.5× 37 0.3× 29 0.2× 19 439
Syed Wasim Canada 9 153 0.3× 80 0.4× 42 0.2× 4 0.0× 35 0.3× 16 427

Countries citing papers authored by C. Robinson

Since Specialization
Citations

This map shows the geographic impact of C. Robinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Robinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Robinson more than expected).

Fields of papers citing papers by C. Robinson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Robinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Robinson. The network helps show where C. Robinson may publish in the future.

Co-authorship network of co-authors of C. Robinson

This figure shows the co-authorship network connecting the top 25 collaborators of C. Robinson. A scholar is included among the top collaborators of C. Robinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Robinson. C. Robinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Ricotta, Emily, Dean Follmann, C. Robinson, et al.. (2022). The 6-minute walk test predicts mortality in a pulmonary nontuberculous mycobacteria-predominant bronchiectasis cohort. BMC Infectious Diseases. 22(1). 75–75. 5 indexed citations
3.
Robinson, C., Sandra D. MacDonald, Ann M. Peterson, et al.. (2020). Antibacterial activity of high-dose nitric oxide against pulmonary Mycobacterium abscessus disease. Access Microbiology. 2(9). acmi000154–acmi000154. 28 indexed citations
4.
Robinson, C., et al.. (2014). Outpatient Physiotherapy Improves Quality of Life for Non Cf Bronchiectasis. Respirology. 19. 96–96. 1 indexed citations
5.
Moore, David F., Ehud Goldin, Monique P. Gelderman, et al.. (2008). Apoptotic abnormalities in differential gene expression in peripheral blood mononuclear cells from children with Fabry disease. Acta Paediatrica. 97(s457). 48–52. 10 indexed citations
6.
Schiffmann, Raphael, Hassan Askari, Margaret Timmons, et al.. (2007). Weekly Enzyme Replacement Therapy May Slow Decline of Renal Function in Patients with Fabry Disease Who Are on Long-Term Biweekly Dosing. Journal of the American Society of Nephrology. 18(5). 1576–1583. 101 indexed citations
7.
Moore, David F., Oleg V. Krokhin, Ronald C. Beavis, et al.. (2007). Proteomics of specific treatment-related alterations in Fabry disease: A strategy to identify biological abnormalities. Proceedings of the National Academy of Sciences. 104(8). 2873–2878. 55 indexed citations
8.
Ries, Markus, David F. Moore, C. Robinson, et al.. (2006). Quantitative dysmorphology assessment in Fabry disease. Genetics in Medicine. 8(2). 96–101. 33 indexed citations
9.
Ries, Markus, Joe T.R. Clarke, Catharina Whybra, et al.. (2006). Enzyme-Replacement Therapy With Agalsidase Alfa in Children With Fabry Disease. PEDIATRICS. 118(3). 924–932. 121 indexed citations
10.
Branch, Donald R., Darinka Sakac, Clifford A. Lingwood, et al.. (2005). Lack of susceptibility of cells from patients with Fabry disease to productive infection with R5 human immunodeficiency virus. AIDS. 19(14). 1543–1546. 24 indexed citations
11.
Ries, Markus, Surya Gupta, David F. Moore, et al.. (2005). Pediatric Fabry Disease. PEDIATRICS. 115(3). e344–e355. 155 indexed citations
12.
Balázs, Tibor & C. Robinson. (1982). Procainamide-induced antinuclear antibodies in beagle dogs. International Journal of Immunopharmacology. 4(4). 327–327. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by I. Willers Breakdown of academic impact, for papers by Laila Arash Breakdown of academic impact, for papers by M. Smith Breakdown of academic impact, for papers by W.P. de Groot Breakdown of academic impact, for papers by Shelley Collins Breakdown of academic impact, for papers by Andrew Lischuk Breakdown of academic impact, for papers by Naresh Kumar Meena Breakdown of academic impact, for papers by M Chaâbouni Breakdown of academic impact, for papers by Lorenzo Pavone Breakdown of academic impact, for papers by Syed Wasim
Rankless by CCL
2026